Literature DB >> 25082465

Cost accounting models used for price-setting of health services: an international review.

Monika Raulinajtys-Grzybek1.   

Abstract

The aim of the article was to present and compare cost accounting models which are used in the area of healthcare for pricing purposes in different countries. Cost information generated by hospitals is further used by regulatory bodies for setting or updating prices of public health services. The article presents a set of examples from different countries of the European Union, Australia and the United States and concentrates on DRG-based payment systems as they primarily use cost information for pricing. Differences between countries concern the methodology used, as well as the data collection process and the scope of the regulations on cost accounting. The article indicates that the accuracy of the calculation is only one of the factors that determine the choice of the cost accounting methodology. Important aspects are also the selection of the reference hospitals, precise and detailed regulations and the existence of complex healthcare information systems in hospitals.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Keywords:  Cost accounting; Cost-based pricing; Health services; Microcosting

Mesh:

Year:  2014        PMID: 25082465     DOI: 10.1016/j.healthpol.2014.07.007

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  2 in total

1.  Mixed method versus full top-down microcosting for organ recovery cost assessment in a French hospital group.

Authors:  Abdelbaste Hrifach; Coralie Brault; Sandrine Couray-Targe; Lionel Badet; Pascale Guerre; Christell Ganne; Hassan Serrier; Vanessa Labeye; Pierre Farge; Cyrille Colin
Journal:  Health Econ Rev       Date:  2016-11-28

2.  Opportunities and challenges for implementing cost accounting systems in the Kenyan health system.

Authors:  Elesban Kihuba; Adrian Gheorghe; Fiammetta Bozzani; Mike English; Ulla K Griffiths
Journal:  Glob Health Action       Date:  2016-06-28       Impact factor: 2.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.